Xie, Jipan <br/><br/>
Comparative effectiveness of everolimus-based therapy versus endocrine monotherapy among postmenopausal women with HR+/HER2- metastatic breast cancer: a retrospective chart review in community oncology practices in the US.  [electronic resource] 

 -  Current medical research and opinion  Jun 2015 
 - 1095-103 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1473-4877 
<br/><br/><label>Standard No.: </label>10.1185/03007995.2015.1021906  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Disease-Free Survival<br/>Everolimus--administration & dosage<br/>Female<br/>Humans<br/>Kaplan-Meier Estimate<br/>Middle Aged<br/>Neoplasm Recurrence, Local--drug therapy<br/>Postmenopause<br/>Proportional Hazards Models<br/>Receptor, ErbB-2--metabolism<br/>Retrospective Studies<br/>Treatment Outcome